Stimulants for depression: On the up and up?
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The use of traditional psychostimulants (methylphenidate and dexamphetamine) and stimulant-like drugs (modafinil and armodafinil) for the treatment of depression is a growing concern given the lack of research evidence supporting their effectiveness. The current article describes the role of stimulants in treating depression--specifically their risks and benefits and their potential use alongside antidepressants. Clinically, the rapid amelioration of depressive symptoms with traditional psychostimulants is often dramatic but short-lived, and this suggests that they likely operate via different mechanisms to conventional antidepressants. More importantly, there is little evidence from randomised controlled trials supporting their efficacy in treating depression, although modafinil has been shown to be effective in reducing prominent depressive symptoms, such as fatigue. Research is urgently required to clarify psychostimulants' mechanisms of action and to evaluate their long-term benefits and risks in the treatment of major and bipolar depression. Ultimately, specificity of action needs to be determined to inform the sophisticated clinical use of psychostimulants in the management of depression. Until then they should only be prescribed if absolutely necessary, and even then their prescription should be facilitatory and time limited unless it is for investigational purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Self-citationConnolly, K. R., & Thase, M. E. (2011) · Drugs · doi:10.2165/11587620-000000000-00000 · Cited by 462
Fava, M., Thase, M. E., & DeBattista, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0112 · Cited by 207
Lavretsky, H., Reinlieb, M., St. Cyr, N., Siddarth, P., Ercoli, L. M., & Senturk, D. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070889 · Cited by 184 · cited 2×
“The effects of methylphenidate occurred during the first 4 weeks of administration, whereas sustained symptomatic improvement reflecting most likely the effects of citalopram only became apparent from week 4 to the end of the study (week 16) (Lavretsky et al., 2015; Nelson, 2015).”
BackgroundPatkar, A. A., Masand, P. S., Pae, C.-U., Peindl, K., Hooper-Wood, C., Mannelli, P., & Ciccone, P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000246212.03530.fd · Cited by 140
Goss, A. J., Kaser, M., Costafreda, S. G., Sahakian, B. J., & Fu, C. H. Y. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08560 · Cited by 133
Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000357500 · Cited by 123 · cited 1×
“Consequently, treatment guidelines do not advocate the use of traditional psychostimulants in the treatment of depression (Carvalho et al., 2014; Malhi et al., 2015a).”
BackgroundRavindran, A. V., Kennedy, S. H., O'Donovan, M. C., Fallu, A., Camacho, F., & Binder, C. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0112 · Cited by 119
Calabrese, J. R., Ketter, T. A., Youakim, J. M., Tiller, J. M., Yang, R., & Frye, M. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05900gry · Cited by 116
Madhoo, M., Keefe, R. S., Roth, R. M., Sambunaris, A., Wu, J., Trivedi, M. H., Anderson, C. S., & Lasser, R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.334 · Cited by 74
Cited by
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
Miskowiak, K., Burdick, K., Martinez‐Aran, A., Bonnin, C., Bowie, C., Carvalho, A., Gallagher, P., Lafer, B., López‐Jaramillo, C., Sumiyoshi, T., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12534 · Cited by 216
Self-citationHickie, I. B., Scott, E. M., Cross, S. P., Iorfino, F., Davenport, T. A., Guastella, A. J., Naismith, S. L., Carpenter, J. S., Rohleder, C., Crouse, J. J., et al. (2019) · Medical Journal of Australia · doi:10.5694/mja2.50383 · Cited by 208
Cognitive dysfunction in major depressive disorder
Knight, M. J., & Baune, B. T. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000378 · Cited by 207
The use of antidepressants in oncology: a review and practical tips for oncologists
Grassi, L. G., Nanni, M. G., Rodin, G., Li, M., & Caruso, R. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx526 · Cited by 109
“Traditional psychostimulants (methylphenidate and dexamphetamine), which show sympathomimetic properties, have been proposed for the treatment of depression in cancer [24, 25].”
Background
Metadata
- Authors
- Malhi, G. S., Byrow, Y., Bassett, D., Boyce, P., Hopwood, M., Lyndon, W., Mulder, R., Porter, R., Singh, A., & Murray, G.
- Affiliations
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
- The University of Western Australia (AU)
- The University of Melbourne (AU)
- University of Otago (NZ)
- Deakin University (AU)
- Swinburne University of Technology (AU)
- Corresponding author
- Malhi, Gin S
- ORCID
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2016-02-23
- Volume
- 50
- Issue
- 3
- Pages
- 203-207
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2312263068
- Cited by
- 46
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 3
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Figshare (submittedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- psychostimulants, depression, methylphenidate, d-amphetamine, modafinil, armodafinil, antidepressant augmentation, major depressive disorder, bipolar depression, fatigue, mechanism of action, efficacy evidence, benefits and risks, drug prescribing
- MeSH terms
- Modafinil, Amphetamine, Central Nervous System Stimulants, Antidepressive Agents, Benzhydryl Compounds, Bipolar Disorder, Depression, Depressive Disorder, Major, Major Depressive Disorder, Dextroamphetamine, Drug Therapy, Combination, Humans, Methylphenidate, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stimulants for depression: On the up and up? https://app.cochat.ai/papers/10.1177/0004867416634208
- The paper
- Malhi, G. S., Byrow, Y., Bassett, D., Boyce, P., Hopwood, M., Lyndon, W., Mulder, R., Porter, R., Singh, A., & Murray, G. (2016). Stimulants for depression: On the up and up? Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867416634208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.